製药产业的ESG趋势

本报告提供製药产业的ESG趋势调查，製药产业的现状，製药产业主要的污染原因，污染的影响，ESG遵守的製药业界的配合，ESG的实施相关的成长机会与课题，案例研究等资料。

目录

第1章 简介

第2章 製药产业概要

• 製药产业的供应链
• 医药品供应链的ESG的阻碍因素

第3章 製药产业对环境的影响

• 医药品污染主要的原因
• 医药品污染的影响
• Scope3受到高度关注

第4章 製药产业的ESG

• ESG概要
• 各种产业ESG的采用增加
• 5个重要的方法中ESG的提案
• 製药产业的ESG的业绩
• 製药产业的ESG投资的剧增
• 主要企业的ESG投资
• 价值链加入ESG的企业

第5章 市场动态

• 製药产业的ESG市场宏观经济趋势
• 製药产业的ESG相关的推进因素
• 製药产业的ESG相关的课题
• 製药产业的ESG相关的机会

第6章 附录:缩写

Highlights:

This report provides a review of ESG trends in the pharmaceutical market, focusing on current trends and developments. The report will have a detailed analysis of key opportunities that would help in the market growth. It will also analyze the major challenges faced by pharmaceutical manufacturers and industry players.

Report Scope:

The report will provide an outline of the global pharmaceutical industry and an ESG overview of the pharmaceutical industry. Qualitative insights on ESG trends and their impact on pharmaceutical manufacturers are provided, along with a detailed analysis of the pharmaceutical industry supply chain with regard to ESG. The report explains the primary drivers, challenges and trends influencing ESG implementation in the pharmaceutical industry.

Report Includes:

• A brief general outlook of the ESG trends in pharmaceutical industry
• Detailed information about ESG-related developments in the pharmaceutical industry and analyses of factors affecting ESG applications
• Discussion of current trends and issues in the pharmaceutical industry, with emphasis on major challenges and opportunities
• Analysis of the whole supply chain of the pharmaceutical industry and its association with ESG
• Information on major causes, and impact of pharmaceutical pollution and a detailed case study related to pharmaceutical pollution

Table of Contents

Chapter 1 Introduction

• 1.1 What is Environmental, Social and Governance (ESG) Compliance?
• 1.2 Study Goals and Objectives
• 1.3 Reasons for Doing This Study
• 1.4 Scope of Report
• 1.5 Intended Audience
• 1.6 Information Sources
• 1.7 Analyst's Credentials
• 1.8 BCC Custom Research
• 1.9 Related BCC Research Reports

Chapter 2 Overview of the Pharmaceutical Industry

• 2.1 Introduction
• 2.2 Pharmaceutical Industry Supply Chain
  • 2.2.1 Manufacturing
  • 2.2.2 Distribution
  • 2.2.3 Providers
  • 2.2.4 Customers and Patients
• 2.3 ESG Deterrents in the Pharmaceutical Supply Chain

Chapter 3 Environmental Impact of the Pharmaceutical Industry

• 3.1 Introduction
• 3.2 Major Causes of Pharmaceutical Pollution
  • 3.2.1 Drug Use, Ingestion and Disposal
  • 3.2.2 Healthcare Institutions
  • 3.2.3 Drug Manufacturers
  • 3.2.4 Agriculture and Argo-Products
  • 3.2.5 Local Pharmaceutical Use and Disposal in Humans
• 3.3 Impact of Pharmaceutical Pollution
  • 3.3.1 Effects on Aquatic Life and Fish
  • 3.3.2 Disrupting Normal Sewerage Process Operations
  • 3.3.3 Drinking Water Impact
  • 3.3.4 Long-Lasting Effects on the Environment
  • 3.3.5 Antibiotic Resistance
  • 3.3.6 Impact on Wildlife
• 3.4 Growing Focus on Scope 3 Emissions
  • 3.4.1 Case Study on Pharmaceutical Pollution

Chapter 4 ESG in the Pharmaceutical Industry

• 4.1 Introduction to ESG
• 4.2 Increasing Adoption of ESG across Various Industries
• 4.3 ESG Proposition in Five Critical Ways
• 4.4 ESG Performance in the Pharmaceutical Industry
• 4.5 Surge in Investment in ESG in the Pharmaceutical Industry
• 4.6 ESG Investments by Key Players
• 4.7 Companies Incorporating ESG into Their Value Chains
  • 4.7.1 Biogen
  • 4.7.2 Collaboration between Novartis and GSK in Africa
  • 4.7.3 Amgen
  • 4.7.4 Enabler

Chapter 5 Market Dynamics

• 5.1 Macroeconomic Trends in the Market for ESG in the Pharmaceutical Industry
  • 5.1.1 Climate Change
  • 5.1.2 Medication Access in Underdeveloped Nations
  • 5.1.3 Drug Pricing and Gouging
• 5.2 ESG-Related Drivers of the Pharmaceutical Industry
• 5.3 ESG-Related Challenges for Pharmaceutical Industry
• 5.4 ESG-Related Opportunities in the Pharmaceutical Industry

Chapter 6 Appendix: Acronyms

List of Tables

• Table 1 : Net-Zero GHG Commitments by Major Life Sciences Companies
• Table 2 : Environmental, Social and Governance Factors in the Pharmaceutical Industry
• Table 3 : ESG Factors in the Pharmaceutical Industry
• Table 4 : Key Environmental, Social and Governance Issues in the Pharmaceutical Industry
• Table 5 : ESG Ranking of Pharmaceutical Industry Players, 2022
• Table 6 : Acronyms Used in This Report

List of Figures

• Figure 1 : Global Market Shares of the Pharmaceutical Industry, by Region, 2021
• Figure 2 : Top 10 Global Pharmaceutical Companies, by Revenue, 2021
• Figure 3 : Pharmaceutical Supply Chain
• Figure 4 : Level of Adoption of ESG across All Industries
• Figure 5 : Level of Adoption of ESG across All Industries by Region, 2021 and 2022